PRVA Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of 1.69% compared to Privia Health Group, Inc.'s net margin of -41.48%. Privia Health Group, Inc.'s return on equity of 3.45% beat DarioHealth Corp.'s return on equity of -41.55%.

Privia Health Group, Inc. has a consensus price target of $31.25, signalling upside risk potential of 42.11%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 59.65%. Given that DarioHealth Corp. has higher upside potential than Privia Health Group, Inc., analysts believe DarioHealth Corp. is more attractive than Privia Health Group, Inc..

Privia Health Group, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.161, suggesting its more volatile than the S&P 500 by 16.051%.

Privia Health Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Privia Health Group, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

Privia Health Group, Inc. quarterly revenues are $580.4M, which are larger than DarioHealth Corp. quarterly revenues of $5M. Privia Health Group, Inc.'s net income of $9.8M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, Privia Health Group, Inc.'s price-to-earnings ratio is 154.86x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Privia Health Group, Inc. is 1.38x versus 6.26x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Mitesco, Inc. has a net margin of 1.69% compared to Privia Health Group, Inc.'s net margin of -106766.67%. Privia Health Group, Inc.'s return on equity of 3.45% beat Mitesco, Inc.'s return on equity of --.

Privia Health Group, Inc. has a consensus price target of $31.25, signalling upside risk potential of 42.11%. On the other hand Mitesco, Inc. has an analysts' consensus of -- which suggests that it could grow by 305.16%. Given that Mitesco, Inc. has higher upside potential than Privia Health Group, Inc., analysts believe Mitesco, Inc. is more attractive than Privia Health Group, Inc..

Privia Health Group, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Mitesco, Inc. has a beta of 5.563, suggesting its more volatile than the S&P 500 by 456.284%.

Privia Health Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mitesco, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Privia Health Group, Inc. pays -- of its earnings as a dividend. Mitesco, Inc. pays out -- of its earnings as a dividend.

Privia Health Group, Inc. quarterly revenues are $580.4M, which are larger than Mitesco, Inc. quarterly revenues of $3K. Privia Health Group, Inc.'s net income of $9.8M is higher than Mitesco, Inc.'s net income of -$3.2M. Notably, Privia Health Group, Inc.'s price-to-earnings ratio is 154.86x while Mitesco, Inc.'s PE ratio is 2.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Privia Health Group, Inc. is 1.38x versus 24.83x for Mitesco, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of 1.69% compared to Privia Health Group, Inc.'s net margin of 9.46%. Privia Health Group, Inc.'s return on equity of 3.45% beat Spok Holdings, Inc.'s return on equity of 10.88%.

Privia Health Group, Inc. has a consensus price target of $31.25, signalling upside risk potential of 42.11%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 54.87%. Given that Spok Holdings, Inc. has higher upside potential than Privia Health Group, Inc., analysts believe Spok Holdings, Inc. is more attractive than Privia Health Group, Inc..

Privia Health Group, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.415, suggesting its less volatile than the S&P 500 by 58.512%.

Privia Health Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.22% to investors and pays a quarterly dividend of $0.31 per share. Privia Health Group, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

Privia Health Group, Inc. quarterly revenues are $580.4M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. Privia Health Group, Inc.'s net income of $9.8M is higher than Spok Holdings, Inc.'s net income of $3.2M. Notably, Privia Health Group, Inc.'s price-to-earnings ratio is 154.86x while Spok Holdings, Inc.'s PE ratio is 16.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Privia Health Group, Inc. is 1.38x versus 2.01x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Vaso Corp. has a net margin of 1.69% compared to Privia Health Group, Inc.'s net margin of 7.55%. Privia Health Group, Inc.'s return on equity of 3.45% beat Vaso Corp.'s return on equity of 9.61%.

Privia Health Group, Inc. has a consensus price target of $31.25, signalling upside risk potential of 42.11%. On the other hand Vaso Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Privia Health Group, Inc. has higher upside potential than Vaso Corp., analysts believe Privia Health Group, Inc. is more attractive than Vaso Corp..

Privia Health Group, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Vaso Corp. has a beta of 0.466, suggesting its less volatile than the S&P 500 by 53.413%.

Privia Health Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vaso Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Privia Health Group, Inc. pays -- of its earnings as a dividend. Vaso Corp. pays out -- of its earnings as a dividend.

Privia Health Group, Inc. quarterly revenues are $580.4M, which are larger than Vaso Corp. quarterly revenues of $22.7M. Privia Health Group, Inc.'s net income of $9.8M is higher than Vaso Corp.'s net income of $1.7M. Notably, Privia Health Group, Inc.'s price-to-earnings ratio is 154.86x while Vaso Corp.'s PE ratio is 11.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Privia Health Group, Inc. is 1.38x versus 0.35x for Vaso Corp.. Usually stocks with elevated PS ratios are considered overvalued.